Preface |
|
xvii | |
Glossary |
|
xix | |
|
The Nature and Investigation of Diseases |
|
|
1 | (24) |
|
|
1 | (1) |
|
Characteristic Features of Diseases |
|
|
2 | (4) |
|
|
2 | (1) |
|
|
3 | (1) |
|
Manifestations of Diseases |
|
|
4 | (1) |
|
|
5 | (1) |
|
Classification of Diseases |
|
|
6 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
|
Types of Pathology Laboratories |
|
|
9 | (1) |
|
Role of Hospital Laboratory Tests |
|
|
10 | (4) |
|
Hospital Laboratory Tests |
|
|
14 | (2) |
|
Evaluation of Laboratory Tests |
|
|
16 | (1) |
|
|
17 | (1) |
|
Quality of Test Results and Clinical Auditing |
|
|
18 | (3) |
|
|
21 | (4) |
|
|
22 | (3) |
|
|
25 | (16) |
|
|
25 | (1) |
|
|
26 | (7) |
|
|
26 | (1) |
|
|
27 | (3) |
|
|
30 | (1) |
|
Protozoa, Fungi and Helminths |
|
|
30 | (1) |
|
Arthropods and Vertebrates |
|
|
31 | (2) |
|
|
33 | (4) |
|
Defensive Virulence Factors |
|
|
33 | (1) |
|
Offensive Virulence Factors |
|
|
34 | (3) |
|
|
37 | (1) |
|
|
38 | (3) |
|
|
39 | (2) |
|
Infectious Diseases and Treatments |
|
|
41 | (32) |
|
|
41 | (1) |
|
|
42 | (1) |
|
Infections of the Eyes, Ears and Central Nervous System |
|
|
42 | (2) |
|
Infections of the Respiratory System |
|
|
44 | (2) |
|
Infections of the Gastrointestinal Tract |
|
|
46 | (2) |
|
Infections of the Urogenital System |
|
|
48 | (5) |
|
Sepsis and Systemic Infections |
|
|
53 | (1) |
|
Investigating Infectious Diseases |
|
|
54 | (5) |
|
|
54 | (1) |
|
|
55 | (1) |
|
Biochemical and Molecular Biological Techniques |
|
|
56 | (3) |
|
Preventing Infectious Diseases |
|
|
59 | (1) |
|
Controlling the Spread of Pathogens |
|
|
60 | (1) |
|
Treatment of Infectious Diseases |
|
|
60 | (9) |
|
|
60 | (1) |
|
|
61 | (3) |
|
Antifungal, Antiprotozoal and Antihelminthic Drugs |
|
|
64 | (2) |
|
|
66 | (1) |
|
|
66 | (3) |
|
|
69 | (4) |
|
|
70 | (3) |
|
|
73 | (26) |
|
|
73 | (1) |
|
|
74 | (1) |
|
|
74 | (5) |
|
|
74 | (1) |
|
|
75 | (1) |
|
|
75 | (2) |
|
|
77 | (1) |
|
Inflammation and the Acute Phase Response |
|
|
77 | (2) |
|
Specific Immune Responses |
|
|
79 | (7) |
|
Roles of Humoral and Cell-Mediated Immunity |
|
|
80 | (1) |
|
|
80 | (5) |
|
|
85 | (1) |
|
|
86 | (1) |
|
Production of a Specific Immune Response |
|
|
87 | (8) |
|
|
89 | (6) |
|
|
95 | (4) |
|
|
97 | (2) |
|
Disorders of the Immune System |
|
|
99 | (28) |
|
|
99 | (1) |
|
Immunodeficiency Diseases |
|
|
100 | (10) |
|
Primary Immunodeficiency Disease |
|
|
100 | (10) |
|
|
110 | (8) |
|
Classification of Autoimmune Disorders |
|
|
110 | (1) |
|
Autoimmune Disorders Affecting Endocrine Glands |
|
|
111 | (2) |
|
Antiglomerular Basement Membrane Disease |
|
|
113 | (1) |
|
|
114 | (1) |
|
|
115 | (1) |
|
Systemic Lupus Erythematosus |
|
|
116 | (2) |
|
Immunological Hypersensitivity |
|
|
118 | (5) |
|
|
118 | (3) |
|
|
121 | (1) |
|
Type III Hypersensitivity |
|
|
121 | (1) |
|
Type IV Delayed Type Hypersensitivity |
|
|
122 | (1) |
|
|
123 | (4) |
|
|
125 | (2) |
|
Transfusion and Transplantation |
|
|
127 | (30) |
|
|
127 | (1) |
|
Blood and Blood Products for Transfusion |
|
|
128 | (1) |
|
The Discovery of the Blood Group Systems |
|
|
129 | (3) |
|
The ABO Blood Group System (ISBT 001) |
|
|
132 | (3) |
|
The Antigens of the ABO System |
|
|
133 | (1) |
|
Antibodies of the ABO Blood Group System |
|
|
134 | (1) |
|
Consequences of ABO Incompatible Transfusions |
|
|
134 | (1) |
|
The Rh Blood Group System (ISBT 004) |
|
|
135 | (3) |
|
Hemolytic Disease of the Newborn |
|
|
136 | (2) |
|
Other Blood Group Systems |
|
|
138 | (1) |
|
Laboratory Determination of Blood Groups |
|
|
139 | (1) |
|
Role of Complement in Transfusion Reactions |
|
|
140 | (1) |
|
|
141 | (2) |
|
Transfusion Related Acute Lung Injury |
|
|
142 | (1) |
|
|
142 | (1) |
|
|
142 | (1) |
|
Graft versus Host Disease |
|
|
143 | (1) |
|
|
143 | (1) |
|
Screening of Blood Donors |
|
|
143 | (2) |
|
Transplantation of Solid Tissues and Organs |
|
|
145 | (2) |
|
Immunological Rejection of Transplants |
|
|
145 | (1) |
|
Causes of Graft Rejection |
|
|
146 | (1) |
|
|
147 | (3) |
|
|
148 | (2) |
|
|
150 | (2) |
|
Hemopoietic Stem Cell Transplantation |
|
|
152 | (2) |
|
Bone Marrow Transplantation |
|
|
152 | (1) |
|
Peripheral Blood Stem Cell Transplantation |
|
|
153 | (1) |
|
Umbilical Cord Stem Cell Transplantation |
|
|
153 | (1) |
|
Identification of Hemopoietic Stem Cells |
|
|
153 | (1) |
|
|
154 | (3) |
|
|
155 | (2) |
|
Disorders of the Endocrine System |
|
|
157 | (46) |
|
|
157 | (2) |
|
|
159 | (3) |
|
Mechanisms of Hormonal Action |
|
|
162 | (2) |
|
Causes of Endocrine Disorders |
|
|
164 | (1) |
|
|
165 | (4) |
|
Disorders of Pituitary Function |
|
|
167 | (2) |
|
|
169 | (3) |
|
Diagnosis and Treatment of Growth Hormone Disorders |
|
|
171 | (1) |
|
Thyroid Hormone Disorders |
|
|
172 | (5) |
|
Diagnosis and Treatment of Thyroid Disorders |
|
|
174 | (3) |
|
Regulation of Blood Glucose |
|
|
177 | (6) |
|
|
178 | (3) |
|
|
181 | (2) |
|
Disorders of the Adrenal Cortex |
|
|
183 | (5) |
|
|
184 | (1) |
|
|
185 | (1) |
|
Congenital Adrenal Hyperplasia |
|
|
186 | (1) |
|
|
187 | (1) |
|
|
188 | (10) |
|
Disorders of Sex Hormones |
|
|
194 | (4) |
|
|
198 | (5) |
|
|
200 | (3) |
|
Disorders of Water, Electrolytes and Urate Balances |
|
|
203 | (22) |
|
|
203 | (1) |
|
|
204 | (4) |
|
|
206 | (1) |
|
|
206 | (2) |
|
Disorders of Water Homeostasis |
|
|
208 | (2) |
|
Disorders of Na+ Homeostasis |
|
|
210 | (1) |
|
Disorders of K+ Homeostasis |
|
|
211 | (1) |
|
Disorders of Ca2+ Homeostasis |
|
|
212 | (4) |
|
Disorders of Phosphate Homeostasis |
|
|
216 | (2) |
|
Disorders of Mg2+ Homeostasis |
|
|
218 | (1) |
|
Disorders of Urate Metabolism |
|
|
219 | (3) |
|
|
222 | (3) |
|
|
223 | (2) |
|
Disorders of Acid-Base Balance |
|
|
225 | (14) |
|
|
225 | (1) |
|
The Production and Transport of Carbon Dioxide |
|
|
226 | (1) |
|
Buffering and the Excretion of H+ |
|
|
227 | (3) |
|
Types of Acid-Base Disorders |
|
|
230 | (3) |
|
Metabolic Acid--Base Disorders |
|
|
230 | (1) |
|
Respiratory Acid--Base Disorders |
|
|
231 | (1) |
|
Mixed Acid--Base Disorders |
|
|
232 | (1) |
|
Investigating Acid--Base Disorders |
|
|
233 | (3) |
|
|
236 | (3) |
|
|
237 | (2) |
|
|
239 | (38) |
|
|
239 | (1) |
|
|
240 | (12) |
|
|
240 | (1) |
|
|
241 | (1) |
|
|
241 | (3) |
|
|
244 | (1) |
|
|
244 | (1) |
|
|
245 | (5) |
|
Minerals and Trace Elements |
|
|
250 | (2) |
|
|
252 | (14) |
|
Protein-Energy Malnutrition |
|
|
252 | (2) |
|
|
254 | (4) |
|
Anorexia Nervosa and Bulimia Nervosa |
|
|
258 | (1) |
|
Disorders of Vitamin Nutrition |
|
|
259 | (4) |
|
Nutritional Disorders of Minerals and Trace Elements |
|
|
263 | (3) |
|
Investigating Nutritional Disorders |
|
|
266 | (5) |
|
Protein-Energy Malnutrition |
|
|
267 | (1) |
|
|
267 | (1) |
|
Anorexia Nervosa and Bulimia Nervosa |
|
|
267 | (1) |
|
|
268 | (2) |
|
Minerals and Trace Elements |
|
|
270 | (1) |
|
General Management of Nutritional Disorders |
|
|
271 | (2) |
|
|
273 | (4) |
|
|
276 | (1) |
|
Disorders of the Gastrointestinal Tract, Pancreas, Liver and Gall Bladder |
|
|
277 | (38) |
|
|
277 | (1) |
|
The Gastrointestinal Tract and its Accessory Organs |
|
|
278 | (3) |
|
|
281 | (8) |
|
|
282 | (1) |
|
|
283 | (2) |
|
|
285 | (4) |
|
Absorption of the Products of Digestion |
|
|
289 | (6) |
|
Activities of the Large Intestine |
|
|
295 | (1) |
|
The Small Intestine and Homeostasis |
|
|
295 | (1) |
|
Hormonal Control of GIT Secretions |
|
|
296 | (1) |
|
Disorders of the GIT and Accessory Organs |
|
|
297 | (15) |
|
Disorders of the Exocrine Pancreas |
|
|
297 | (1) |
|
Disorders of the Liver, Gall Bladder and Bile Duct |
|
|
298 | (4) |
|
|
302 | (4) |
|
Disorders of the Small Intestine |
|
|
306 | (5) |
|
Disorders of the Large Intestine |
|
|
311 | (1) |
|
|
312 | (3) |
|
|
313 | (2) |
|
|
315 | (30) |
|
|
315 | (1) |
|
Drug Action, Metabolism, Distribution and Excretion |
|
|
316 | (2) |
|
Physiological Detoxification Mechanisms |
|
|
318 | (3) |
|
|
321 | (1) |
|
|
321 | (20) |
|
|
321 | (4) |
|
|
325 | (2) |
|
|
327 | (4) |
|
|
331 | (1) |
|
|
331 | (1) |
|
|
332 | (1) |
|
|
333 | (1) |
|
|
334 | (1) |
|
|
335 | (6) |
|
|
341 | (4) |
|
|
342 | (3) |
|
|
345 | (34) |
|
|
345 | (1) |
|
Blood Cells and Platelets |
|
|
346 | (3) |
|
|
349 | (3) |
|
Key Properties of Hemoglobin |
|
|
350 | (1) |
|
Embryonic and Fetal Hemoglobins |
|
|
351 | (1) |
|
Hemostasis and Blood Clotting |
|
|
352 | (4) |
|
|
353 | (1) |
|
|
354 | (1) |
|
|
355 | (1) |
|
|
355 | (1) |
|
|
356 | (1) |
|
|
356 | (5) |
|
|
357 | (2) |
|
|
359 | (2) |
|
|
361 | (7) |
|
|
362 | (3) |
|
|
365 | (3) |
|
Glucose 6-Phosphate Dehydrogenase Deficiency (G6PD) |
|
|
368 | (2) |
|
|
369 | (1) |
|
Clinical Aspects of Clotting |
|
|
370 | (2) |
|
Vitamin K and Anticoagulants |
|
|
370 | (1) |
|
|
371 | (1) |
|
Thrombocytopenia and Thrombocytosis |
|
|
372 | (3) |
|
|
375 | (4) |
|
|
377 | (2) |
|
Disorders of the Cardiovascular System |
|
|
379 | (36) |
|
|
379 | (1) |
|
The Heart and Circulatory Systems |
|
|
380 | (3) |
|
|
383 | (3) |
|
|
384 | (2) |
|
|
386 | (1) |
|
|
386 | (1) |
|
|
386 | (3) |
|
Investigating Cardiac Function in Health and Disease |
|
|
389 | (3) |
|
The Electrocardiogram (ECG) |
|
|
389 | (2) |
|
|
391 | (1) |
|
Cardiac Catheterization (Angiography) |
|
|
391 | (1) |
|
Angiography and Radiographic Visualization |
|
|
391 | (1) |
|
|
391 | (1) |
|
|
392 | (1) |
|
|
392 | (3) |
|
Atrial Fibrillation and Flutter |
|
|
393 | (1) |
|
|
393 | (1) |
|
|
394 | (1) |
|
|
394 | (1) |
|
|
395 | (1) |
|
|
395 | (1) |
|
|
395 | (1) |
|
|
396 | (1) |
|
|
396 | (1) |
|
|
396 | (1) |
|
|
397 | (2) |
|
Dilated Congestive Cardiomyopathy |
|
|
397 | (1) |
|
Hypertrophic Cardiomyopathy |
|
|
398 | (1) |
|
Restrictive Cardiomyopathy |
|
|
398 | (1) |
|
|
399 | (1) |
|
|
399 | (1) |
|
Atherosclerosis or Arteriosclerosis |
|
|
400 | (4) |
|
|
400 | (2) |
|
Cholesterol and Lipoproteins |
|
|
402 | (2) |
|
|
404 | (2) |
|
Plasma Enzymes in Myocardial Infarction |
|
|
405 | (1) |
|
|
405 | (1) |
|
|
405 | (1) |
|
|
406 | (1) |
|
Disorders of Arteries and Veins |
|
|
407 | (3) |
|
Peripheral Arterial Disease |
|
|
407 | (1) |
|
|
407 | (1) |
|
|
407 | (1) |
|
|
408 | (1) |
|
|
409 | (1) |
|
|
409 | (1) |
|
Clinical Problems Associated with Blood Pressure |
|
|
410 | (2) |
|
Low Blood Pressure (Hypotension) |
|
|
410 | (1) |
|
|
410 | (1) |
|
High Blood Pressure (Hypertension) |
|
|
411 | (1) |
|
|
412 | (3) |
|
|
414 | (1) |
|
|
415 | (34) |
|
|
415 | (1) |
|
|
416 | (1) |
|
DNA Replication and the Cell Cycle |
|
|
417 | (4) |
|
|
418 | (3) |
|
|
421 | (1) |
|
Inheritance and Mutations |
|
|
421 | (3) |
|
Sex-linked Genetic Diseases |
|
|
423 | (1) |
|
|
424 | (4) |
|
Consequences of an Enzyme Deficiency |
|
|
424 | (4) |
|
National Screening Programs for Inherited Diseases |
|
|
428 | (1) |
|
Chromosomes and the Human Karyotype |
|
|
428 | (4) |
|
|
430 | (2) |
|
Chromosomal Mutations or Aberrations |
|
|
432 | (5) |
|
|
433 | (1) |
|
|
434 | (1) |
|
|
435 | (1) |
|
|
435 | (2) |
|
Variations in Chromosome Numbers |
|
|
437 | (4) |
|
|
437 | (3) |
|
|
440 | (1) |
|
Detecting, Diagnosing and Screening Human Genetics Diseases |
|
|
441 | (4) |
|
Detection of Hereditary Diseases |
|
|
442 | (3) |
|
|
445 | (4) |
|
|
446 | (3) |
|
Membrane, Organelle and Cytoskeletal Disorders |
|
|
449 | (26) |
|
|
449 | (1) |
|
Nucleus and Nucleocytoplasmic Transport |
|
|
450 | (3) |
|
Clinical Aspects of Nucleocytoplasmic Transport |
|
|
453 | (1) |
|
Plasma Membrane Disorders |
|
|
453 | (3) |
|
|
454 | (2) |
|
|
456 | (5) |
|
Causes of Mitochondrial Disorders |
|
|
457 | (3) |
|
Diagnosis and Treatment of Mitochondrial Disorders |
|
|
460 | (1) |
|
|
461 | (2) |
|
Diagnosis and Treatment of Peroxisomal Disorders |
|
|
462 | (1) |
|
|
463 | (2) |
|
Diagnosis and Treatment of Lysosomal Storage Disorders |
|
|
465 | (1) |
|
|
465 | (6) |
|
|
467 | (3) |
|
Hereditary Elliptocytosis and Spherocytosis |
|
|
470 | (1) |
|
|
471 | (4) |
|
|
473 | (2) |
|
|
475 | (40) |
|
|
475 | (1) |
|
Classification of Cancer Types |
|
|
476 | (1) |
|
|
476 | (2) |
|
Molecular Biology of Cancer |
|
|
478 | (2) |
|
|
478 | (1) |
|
|
479 | (1) |
|
|
480 | (7) |
|
|
480 | (1) |
|
|
481 | (1) |
|
|
482 | (2) |
|
|
484 | (1) |
|
|
485 | (1) |
|
|
486 | (1) |
|
General Diagnosis of Cancer |
|
|
487 | (5) |
|
Clinical Tests for Cancer |
|
|
487 | (5) |
|
General Treatment of Cancer |
|
|
492 | (6) |
|
|
493 | (4) |
|
|
497 | (1) |
|
|
497 | (1) |
|
Specific Types of Cancers |
|
|
498 | (13) |
|
|
498 | (2) |
|
|
500 | (2) |
|
|
502 | (3) |
|
|
505 | (2) |
|
|
507 | (4) |
|
|
511 | (4) |
|
|
512 | (3) |
|
|
515 | (16) |
|
|
515 | (1) |
|
Aging of Cells, Tissues, Organs and Systems |
|
|
516 | (3) |
|
|
516 | (1) |
|
|
516 | (1) |
|
|
516 | (1) |
|
|
517 | (2) |
|
|
519 | (3) |
|
|
519 | (2) |
|
|
521 | (1) |
|
|
522 | (5) |
|
|
522 | (1) |
|
|
522 | (1) |
|
|
523 | (1) |
|
|
523 | (1) |
|
|
523 | (1) |
|
|
523 | (4) |
|
Calorie Restriction and Aging |
|
|
527 | (1) |
|
Investigations and Management of the Elderly |
|
|
527 | (1) |
|
|
528 | (3) |
|
|
529 | (2) |
|
|
531 | (10) |
|
|
531 | (1) |
|
|
531 | (1) |
|
|
531 | (1) |
|
|
532 | (1) |
|
|
532 | (1) |
|
|
533 | (1) |
|
|
533 | (1) |
|
|
534 | (1) |
|
|
535 | (1) |
|
|
535 | (1) |
|
|
536 | (1) |
|
|
537 | (1) |
|
|
537 | (1) |
|
|
538 | (1) |
|
|
538 | (1) |
|
|
539 | (1) |
|
|
539 | (1) |
|
|
540 | (1) |
|
|
541 | (10) |
|
|
541 | (1) |
|
|
541 | (1) |
|
|
542 | (1) |
|
|
542 | (1) |
|
|
543 | (1) |
|
|
543 | (1) |
|
|
543 | (1) |
|
|
544 | (1) |
|
|
545 | (1) |
|
|
545 | (1) |
|
|
546 | (1) |
|
|
546 | (1) |
|
|
547 | (1) |
|
|
548 | (1) |
|
|
548 | (1) |
|
|
549 | (1) |
|
|
549 | (1) |
|
|
550 | (1) |
Index |
|
551 | |